Nabriva Therapeutics AG was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.  This continues the recent uptrend for the company as the stock is now up almost 58% in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate moved higher over the same timeframe, suggesting more solid trading could be ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Nabriva Therapeutics currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Nabriva Therapeutics AG Price

 

Nabriva Therapeutics AG Price | Nabriva Therapeutics AG Quote

A better-ranked stock in the Medical – Biomedical and Genetics space is Heska Corporation , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

    
Is NBRV going up? Or down? Predict to see what others think: Up or Down

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>